Weiguo Ye Insider Trades & Stock Holdings

Chief Operating Officer · Gyre Therapeutics, Inc. · Latest filing Jun 18, 2026

Weiguo Ye, Chief Operating Officer at Gyre Therapeutics, Inc. has 4 Form 4 trades on file since Jun 11, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($36.33K), net -$36.33K. Latest filing: disposed of 3K shares of $GYRE on Jun 18, 2026 at $6.35.

Trades on file

4

Open-market bought

$0

Open-market sold

$36.33K

Net open-market

-$36.33K

Latest filing

Jun 18, 2026

All insider trades by Weiguo Ye

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 18, 2026	$GYRE	Sell (Open-market sale)	3K	$6.35	$19.05K			-0.3%	-5.9%		Chief Operating Officer		—
Jun 18, 2026	$GYRE	Buy (Option exercise)	3K	$0.75	$2.25K			-0.3%	-5.9%		Chief Operating Officer		—
Jun 11, 2026	$GYRE	Sell (Open-market sale)	2.80K	$6.17	$17.28K			+3.1%	+4.6%		Chief Operating Officer		Read
Jun 11, 2026	$GYRE	Buy (Option exercise)	2.80K	$0.75	$2.10K			+3.1%	+4.6%		Chief Operating Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Weiguo Ye traded

• $GYRE

Frequently asked questions

Has Weiguo Ye been buying or selling stock?

Weiguo Ye has 0 open-market purchases and 2 open-market sales on file, net -$36.33K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Weiguo Ye's latest insider trade?

disposed of 3K shares of $GYRE on Jun 18, 2026 at $6.35.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.